As of Dec 09
| +0.05 / +2.63%|
The 3 analysts offering 12-month price forecasts for OHR Pharmaceutical Inc have a median target of 10.00, with a high estimate of 13.00 and a low estimate of 5.00. The median estimate represents a +412.82% increase from the last price of 1.95.
The current consensus among 3 polled investment analysts is to Buy stock in OHR Pharmaceutical Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.